Folic acid in general medicine and dermatology

References

• Lucock M., Yates Z. Folic acid – vitamin and panacea or genetic time bomb?. Nat Rev Genet 2005; 6: 235–40
   PubMed Web of Science ®Google Scholar
• McKillop D. J., Pentieva K., Daly D., McPartlin J. M., Hughes J., Strain J. J., et al. Br J Nutr 2002; 88: 681–8
   PubMed Web of Science ®Google Scholar
• Eichholzer M., Tonz O., Zimmermann R. Folic acid: a public‐health challenge. Lancet 2006; 367: 1352–61
   PubMed Web of Science ®Google Scholar
• Bonaa K. H., Njolstad I., Ueland P. M., Schirmer H., Tverdal A., Steigen T., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354: 1578–88
   PubMed Web of Science ®Google Scholar
• Zhang S. M., Hankinson S. E. Folate intake and risk of breast cancer characterized by hormone receptor status. Cancer Epidemiol Biomarkers Prev 2005; 14: 2004–8
   PubMed Web of Science ®Google Scholar
• Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000; 71: 121–38
   PubMed Web of Science ®Google Scholar
• Fiore J. J., Kemeny N. E., Mehta B. M. Systemic absorption of a leucovorin mouth wash: a pharmacologic study. Cancer Invest 1987; 5: 109–11
   PubMed Web of Science ®Google Scholar
• Levitt M., Nixon F., Pincus J. H., Bertino J. R. Transport characteristics of folate in cerebrospinal fluid; a study utilizing doubly labeled 5‐methyltetrahydrofolate and 5‐formyltetrahydrofolate. J Clin Invest 1971; 50: 1301–8
   PubMed Web of Science ®Google Scholar
• Russell R. M., Golner B. B., Krasinski S. D., Sadowski J. A., Suter P. M., Braun C. L., et al. Effect of antiacid and H2 receptor antagonists on the intestinal absorption of folic acid. J Lab Clin Med 1988; 112: 458–63
   PubMed Web of Science ®Google Scholar
• Lambie D. G., Johnson R. H. Drugs and folate metabolism. Drugs 1985; 30: 145–55
   Google Scholar
• Sarazaga A., Garcia de Lorenzo A., Montanes P., Culebras J. M. Folates in human nutrition. Different clinical situations in which folate deficiencies exist. Nutr Hosp 1991; 6: 207–26
   Google Scholar
• Halsted C. H. The intestinal absorption of dietary folates in health and disease. J Am Coll Nutr 1989; 8: 650–8
   PubMed Web of Science ®Google Scholar
• Björkegren K., Svärdsudd K. Reported symptoms and clinical findings in relation to serum cobalamin, folate, methylmalonic acid and total homocysteine among elderly Swedes: a population‐based study. J Intern Med 2003; 254: 343–52
   PubMed Web of Science ®Google Scholar
• Juhlin L., Olsson M. J. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol 1997; 77: 460–2
   PubMed Web of Science ®Google Scholar
• Montes L. F., Diaz M. L., Lajaous J., Garcia N. J. Folic acid and vitamin B12 in vitiligo: A nutritional approach. Cutis 1992; 50: 39–42
   PubMedGoogle Scholar
• Tjioe M., Gerritsen M. J., Juhlin L., van de Kerkhof P. C. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002; 82: 369–72
   PubMed Web of Science ®Google Scholar
• Meiss F., Marsch W. C., Fischer M. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. Eur J Dermatol 2006; 16: 159–62
   Google Scholar
• Browning C. E., Callen J. P. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 2006; 142: 75–8
   Google Scholar
• Kolbach D. N., Veraart J. C. J. M., Hamulyak K., Spaapen L. J. M. Recurrent leg ulcers in a young man with hyperhomocysteinemia, Factor V Leiden, and impaired fibrinolysis. Acta Derm Venereol 2002; 82: 52–4
   Google Scholar
• Cocuroccia B., Tonanzi T., Menaguale G., Fazio M., Girolomoni G. Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia. Eur J Dermatol 2002; 12: 360–3
   Google Scholar
• Rocha‐Pereira P., Santos‐Silva A., Rebelo I., Figueiredo A., Quintanilha A., Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001; 303: 33–9
   PubMed Web of Science ®Google Scholar
• Pearce D. J., Morrison A. E., Higgins K. B., Crane M. M., Balkrishnan R., Fleischer A. B., Jr., et al. The comorbid state of psoriasis patients in a University dermatology practice. J Dermatolog Treat 2005; 16: 319–23
   PubMed Web of Science ®Google Scholar
• Henseler T., Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982–6
   PubMed Web of Science ®Google Scholar
• Mallbris L., Akre O., Granath F., Yin L., Lindelof B., Ekbom A., et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004; 19: 225–30
   PubMed Web of Science ®Google Scholar
• Herron M. D., Hinckley M., Hoffman M. S., Papenfuss J., Hansen C. B., Callis K. P., et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527–34
   PubMed Web of Science ®Google Scholar
• Naldi L., Chatenoud L., Linder D., Belloni Fortina A., Peserico A., Virgili A. R., et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case–control study. J Invest Dermatol 2005; 125: 61–7
   PubMed Web of Science ®Google Scholar
• Kural B. V., Örem A., Cimşit G., Uydu H. A., Yandi Y. E., Alver A. Plasma homocysteine and its relationship with atherothrombotic markers in psoriatic patients. Clinica Chimica Acta 2003; 332: 23–30
   PubMed Web of Science ®Google Scholar
• Hild H. Folate losses from the skin in exfoliative dermatitis. Arch Intern Med 1969; 123: 51–4
   Google Scholar
• Malerba M., Gisondi P., Radaeli A., Sala R., Calzavara Pinton P., Girolomoni G. Br J Dermatol 2006; 155: 1165–69
   PubMed Web of Science ®Google Scholar
• Najarian D. J., Gottlieb A. B. Connections between psoriasis and Crohn's disease. J Am Acad Dermatol 2003; 48: 805–21
   PubMed Web of Science ®Google Scholar
• Scarpa R., Manguso F., D'Arienzo A. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 2000; 27: 1241–6
   PubMed Web of Science ®Google Scholar
• Schatteman L., Mielants H., Veys E. M. Gut inflammation in psoriatic arthritis: A prospective ileocolonoscopic study. J Rheumatol 1995; 22: 680–3
   PubMedGoogle Scholar
• Fry L., Macdonald A., Almeyda J., Griffin C. J., Hoffbrand A. V. The mechanism of folate deficiency in psoriasis. Br J Dermatol 1971; 84: 539–44
   Web of Science ®Google Scholar
• Solini A., Santini E., Ferrannini E. Effect of short‐term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond) 2006; 30: 1197–202
   PubMed Web of Science ®Google Scholar
• Boffa M. J. Methotrexate for psoriasis: Current European practice. A postal survey. J Eur Acad Dermatol Venereol 2005; 19: 196–202
   Google Scholar
• Strober B. E., Menon K. Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol 2005; 53: 652–9
   PubMed Web of Science ®Google Scholar
• Salim A., Tan E., Ilchyshyn A., Berth‐Jones J. Folic acid supplementation during treatment of psoriasis with methotrexate: A randomized, double‐blind, placebo‐controlled trial. Br J Dermatol 2006; 154: 1169–74
   PubMed Web of Science ®Google Scholar
• Van Ede A. E., Laan R. F., Rood M. J., Huizinga T. W., van de Laar M. A., van Denderen C. J., et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty‐eight week, multicenter, randomized, double‐blind, placebo‐controlled study. Arthritis Rheum 2001; 44: 1515–24
   PubMed Web of Science ®Google Scholar
• Joyce D. A., Will R. K., Hoffman D. M., Laing B., Blackbourn S. J. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann Rheum Dis 1991; 12: 913–14
   Google Scholar
• Hartman M., van Ede A., Severens J. L., Laan R. F., van de Putte L., van der Wilt G. J. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. J Rheumatol 2004; 31: 902–8
   Google Scholar
• Tamura T., Goldenberg R. L., Johnston K. E., Cliver S. P., Hoffman H. J. Serum concentrations of zinc, folate, vitamins A and E, and proteins, and their relationships to pregnancy outcome. Acta Obstet Gynecol Scand 1997; 165: 63–70
   Google Scholar
• Bjorklund N. K., Gordon R. A hypothesis linking low folate intake to neural tube defects due to failure of post‐translation methylation of the cytoskeleton. Int J Dev Biol 2006; 50: 135–41
   PubMedGoogle Scholar
• Botto L. D., Olney R. S., Erickson J. D. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet 2004; 125: 12–21
   Web of Science ®Google Scholar
• Bailey L. B., Berry R. J. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 2005; 81: 1213S–17S
   PubMed Web of Science ®Google Scholar
• Selhub J., Jacques P. F., Rosenberg I. H., et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991–1994): Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999; 131: 331–9
   PubMed Web of Science ®Google Scholar
• Wald N. J., Law M. R., Morris J. K., Wald D. S. Quantifying the effect of folic acid. Lancet 2001; 358: 2069–73
   PubMed Web of Science ®Google Scholar
• Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta‐analysis. JAMA 2002; 288: 2015–22
   PubMed Web of Science ®Google Scholar
• Weiss N., Hilge R., Hoffmann U. Mild hyperhomocysteinemia: Risk factor or just risk predictor for cardiovascular disease?. Vasa 2004; 33: 191–203
   Google Scholar
• Nygard O., Refsum H., Ueland P. M., Vollset S. E. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine study. Am J Clin Nutr 1998; 67: 263–70
   PubMed Web of Science ®Google Scholar
• Moat S. J., McDowell I. F. Homocysteine and endothelial function in human studies. Semin Vasc Med 2005; 5: 172–82
   PubMedGoogle Scholar
• Kerkeni M., Addad F., Chauffert M., Myara A., Ben Farhat M., Miled A., et al. Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem 2006; 52: 53–8
   PubMed Web of Science ®Google Scholar
• Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: Meta‐analysis of randomized trials. BMJ 1998; 316: 894–8
   PubMedGoogle Scholar
• Kluijtmans L. A., van den Heuvel L. P., Boers G. H. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene in a genetic risk factor in cardiovascular disease. Am J Hum Genet 1996; 58: 35–41
   PubMed Web of Science ®Google Scholar
• Guenther B. D., Sheppard C. A., Tran P., Rozen R., Matthews R. G., Ludwig M. The structure and properties of methylenetetrahydrofolate reductase from E. coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 1999; 6: 359–65
   PubMedGoogle Scholar
• Homocysteine Lowering Trialists' Collaboration. Dose‐dependent effects of folic acid on blood concentrations of homocysteine: A meta‐analysis of the randomized trials. Am J Clin Nutr 2005; 82: 806–12
   PubMed Web of Science ®Google Scholar
• Righetti M., Serbelloni P., Milani S., Ferrario G. Homocysteine‐lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients. Blood Purif 2006; 244: 379–86
   Google Scholar
• Lonn E., Yusuf S., Arnold M. J., Sheridan P., Pogue J., Micks M., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567–77
   PubMed Web of Science ®Google Scholar
• Bostom A. G., Selhub J., Jacques P. F., Rosenberg I. H. Power shortage: Clinical trials testing the ‘homocysteine hypothesis’ against a background of folic acid‐fortified cereal grain flour. Ann Intern Med 2001; 135: 133–7
   PubMedGoogle Scholar
• Lange H., Suryapranata H., De Luca G., Borner C., Dille J., Kallmayer K., et al. Folate therapy and in‐stent restenosis after coronary stenting. N Engl J Med 2004; 350: 2673–81
   PubMed Web of Science ®Google Scholar
• Davey Smith G., Ebrahim S. Folate supplementation and cardiovascular disease. Lancet 2005; 366: 1679–81
   Google Scholar
• Rimm E. B., Willett W. C., Hu F. B., Sampson L., Colditz G. A., Manson J. E., et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998; 279: 359–64
   PubMed Web of Science ®Google Scholar
• Eichholzer M., Luthy J., Moser U., Fowler B. Folate and the risk of colorectal, breast and cervix cancer: The epidemiological evidence. Swiss Med Wkly 2001; 131: 539–49
   PubMed Web of Science ®Google Scholar
• Hu F. B., Willett W. C. Diet and coronary heart disease: Findings from the Nurses' Health Study and Health Professionals' Follow‐up Study. J Nutr Health Aging 2001; 5: 132–8
   PubMedGoogle Scholar
• Chen J., Giovannucci E., Kelsey K., et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56: 4862–4
   PubMed Web of Science ®Google Scholar
• Kim Y. I. Folate and cancer prevention: A new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev 1999; 57: 314–21
   PubMed Web of Science ®Google Scholar
• Charles D., Ness A. R., Campbell D., Davey Smith G., Hall M. H. Taking folate in pregnancy and risk of maternal breast cancer. BMJ 2004; 329: 1375–6
   PubMed Web of Science ®Google Scholar
• Zhang S., Hunter D. J., Hankinson S. E., et al. A prospective study of folate intake and the risk of breast cancer. JAMA 1999; 281: 1632–7
   PubMed Web of Science ®Google Scholar
• Hirakawa K., Suzuki H., Oikawa S., Kawanishi S. Sequence‐specific DNA damage induced by ultraviolet A‐irradiated folic acid via its photolysis product. Arch Biochem Biophys 2003; 410: 261–8
   PubMed Web of Science ®Google Scholar
• Young S. N., Ghadirian A. M. Folic acid and psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13: 841–63
   PubMed Web of Science ®Google Scholar
• Alpert J. E., Fava M. Nutrition and depression: The role of folate. Nutr Rev 1997; 55: 145–9
   PubMed Web of Science ®Google Scholar
• McMahon J. A., Green T. J., Skeaff C. M., Knight R. G., Mann J. I., Williams S. M. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354: 2764–72
   PubMed Web of Science ®Google Scholar
• Papakostas G. I., Petersen T., Lebowitz B. D., Mischoulon D., Ryan J. L., Nierenberg A. A., et al. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol 2005; 8: 523–8
   PubMed Web of Science ®Google Scholar
• Taylor M. J., Carney S. M., Goodwin G. M., Geddes J. R. Folate for depressive disorders: Systematic review and meta‐analysis of randomized controlled trials. J Psychopharmacol 2004; 18: 251–6
   PubMed Web of Science ®Google Scholar
• Campbell N. R. How safe are folic acid supplements?. Arch Intern Med 1996; 156: 1638–44
   PubMed Web of Science ®Google Scholar
• Mangoni A. A. Folic acid, inflammation, and atherosclerosis: False hopes or the need for better trials?. Clin Chim Acta 2006; 367: 11–19
   Google Scholar
• Harbour R., Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323: 334–6
   PubMed Web of Science ®Google Scholar